| Enrolling By Invitation | A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) Graves' Disease | Phase 2 | 2026-01-26 |
| Enrolling By Invitation | An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Poly Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | 2025-08-28 |
| Recruiting | Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Primary Sjögren's Syndrome | Phase 2 | 2025-06-30 |
| Recruiting | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease | Phase 2 | 2025-06-19 |
| Recruiting | Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myastheni Generalized Myasthenia Gravis | Phase 3 | 2025-05-27 |
| Recruiting | IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | 2025-03-18 |
| Recruiting | A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Ery Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus | Phase 2 | 2025-02-19 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Dif Rheumatoid Arthritis | Phase 2 | 2025-01-10 |
| Recruiting | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease | Phase 2 | 2024-12-17 |
| Completed | A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease Graves Disease | Phase 2 | 2023-05-15 |
| Completed | Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease Thyroid Eye Disease | Phase 3 | 2023-01-05 |
| Active Not Recruiting | To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | 2022-12-15 |
| Completed | Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease Thyroid Eye Disease | Phase 3 | 2022-11-23 |
| Active Not Recruiting | Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease Thyroid Eye Disease | Phase 3 | 2022-11-06 |
| Active Not Recruiting | Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Pa Generalized Myasthenia Gravis | Phase 3 | 2022-06-27 |
| Terminated | To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAI Warm Autoimmune Hemolytic Anemia | Phase 2 | 2020-08-11 |
| Terminated | ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophth Graves' Ophthalmopathy (GO) | Phase 2 | 2019-07-23 |
| Completed | A Study of RVT-1401 in Myasthenia Gravis (MG) Patients Myasthenia Gravis | Phase 2 | 2019-05-21 |
| Completed | Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) Graves' Ophthalmopathy | Phase 2 | 2019-04-22 |